ENFN Investors Get Opportunity to Join Enfusion, Inc. Securities Fraud Investigation with Schall Law Firm

Schall Law Firm, a national law firm focused on shareholder rights litigation, announces that it is investigating claims alleging violations of the securities laws on behalf of investors of Enfusion, Inc. (“Enfusion” or “the Company”) (NYSE: ENFN).

The investigation focuses on whether the company made false and/or misleading statements and/or failed to disclose information that was relevant to investors. Enfusion reported its financial results for the second quarter of 2024 on August 6, 2024. The company missed consensus estimates for both earnings and revenue. On this news, shares of Enfusion fell 7.86% on the same day.